Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
about
The molecular mechanisms of offspring effects from obese pregnancyHuman obesity and endothelium-dependent responsivenessCharacterization of the human endothelial nitric-oxide synthase promoterRegulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytesTumor necrosis factor α decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limbNitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytesEmerging concepts regarding pannexin 1 in the vasculature.Regulation of obesity and insulin resistance by nitric oxideEndothelial protective and antishock effects of a selective estrogen receptor modulator in rats.Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1.Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short durationPosttranscriptional and transcriptional regulation of endothelial nitric-oxide synthase during hypoxia: the role of microRNAs.Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative StressThe role of inflammation in the pathology of preeclampsiaNitric oxide in the pathogenesis of vascular disease.Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunctionTargeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training.Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric-oxide synthase expression in placental artery endothelial cells.HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cellsEffect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.Testosterone: a natural tonic for the failing heart?Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.Soluble guanylate cyclase beta1-subunit expression is increased in mononuclear cells from patients with erectile dysfunction.Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial.The nitric oxide pathway and oxidative stress in heart failure.Free radicals, diabetes and endothelial dysfunction.Obesity, aerobic exercise, and vascular disease: the role of oxidant stress.Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro.Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery.The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence.Neuroprotection mediated by changes in the endothelial actin cytoskeleton.Adenosine prevents TNFα-induced decrease in endothelial mitochondrial mass via activation of eNOS-PGC-1α regulatory axis.Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock.Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circleActivation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice
P2860
Q27008079-C69BC904-53B5-48A7-B7F1-4D0C4B77A542Q27021665-350544CA-DBAE-4FFA-88E7-139F18EBC0C2Q28294946-8E3DC122-2AB8-4DA0-B3CF-54ED5E0CD1E6Q28565119-D6629F7F-6E10-4686-BAFF-DA876BAD9439Q28567166-4F5BDA3E-F789-4092-B07A-924FF9A51E34Q28578672-C51A6EC4-DD2A-48C3-80BD-B6EF8F904661Q30279302-32A25741-1F74-477D-963E-6C60E4B8AB7AQ30363035-321DE349-840E-47F0-A5C7-3DFFC62CD3DDQ31833919-6DD93AB5-5FD6-4B81-BCEA-3D319FFAAE03Q33265103-11C94B93-B341-4FE8-8F80-AA012B763FB3Q33358641-6977E59B-59A0-4D5B-9D6F-988DF3DAD25FQ33593925-604C7112-CBBA-415A-84E8-3E96E3583679Q33634719-92723D8F-02DA-46DA-A530-63FEAF82143DQ33736693-8532869A-2B25-40CA-A8E2-FCA85420FD13Q33834419-5BE3539E-1418-4CD1-851A-A7F3FBBDDD86Q33843539-C59AA3D3-AC4C-4EA2-9925-5BC318807A74Q33861097-6D948BE3-B80B-44FA-95B2-3E542A9595DBQ33863759-C044C45C-3649-4370-9A5E-869C639241C8Q33885073-9F20B6B4-AEC6-4EAB-8579-10D496AC33A8Q33954940-2B3C5BBE-4B30-4720-B4CC-C57A4F910C5AQ34012826-5C62CB10-96C6-4F22-8573-FF9D0236B2BAQ34058722-4F9423AE-1FFA-4246-912E-CE5D31E74488Q34077617-E8996563-38C9-4BE8-BDC1-13CC81259FC8Q34146925-82BF3952-7D9F-461B-A561-8379D2ACC713Q34467128-4935F77F-E254-4A73-90C8-9AE0AD194109Q34501092-E634453C-2B4F-4428-8A86-DC7AA2908849Q34626098-83D6B98D-D382-4908-A980-1C7B18AD3C49Q34667665-1A046B24-E682-43EF-9A85-75D0A0E26177Q34722600-AC3D8DD8-FA14-4E2F-ABFD-F8AFF9230528Q34844350-7B0B49F2-03F1-48DC-A4F8-EC6384117FAAQ35026148-EBB7D1B9-FD9E-4030-A196-1C10EA9A21FDQ35045161-18DFB274-44AA-4583-A62C-14152FA592EAQ35049195-7AE6B7DF-079E-45F3-84C6-196E6F1C4132Q35055194-8F6C99AA-633F-4B05-AB99-C482A94A715BQ35106116-3AAF5699-B03A-4B7F-B04B-AB9A31631EF4Q35128290-E4F405DE-5919-4533-A001-C4CCE35DD973Q35184659-7B2E42D0-7428-40EC-B045-16585CBCBE8AQ35214654-143F06FB-58B7-499F-BE74-AB64AC4A10E7Q35223968-924885D8-AC02-4309-AFF4-197AC306FF28Q35484895-4380702A-5C66-46B7-ADFD-880F902F71C4
P2860
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Tumor necrosis factor downregu ...... A by shortening its half-life.
@en
Tumor necrosis factor downregu ...... A by shortening its half-life.
@nl
type
label
Tumor necrosis factor downregu ...... A by shortening its half-life.
@en
Tumor necrosis factor downregu ...... A by shortening its half-life.
@nl
prefLabel
Tumor necrosis factor downregu ...... A by shortening its half-life.
@en
Tumor necrosis factor downregu ...... A by shortening its half-life.
@nl
P2093
P356
P1433
P1476
Tumor necrosis factor downregu ...... A by shortening its half-life.
@en
P2093
Burnett JC Jr
Perrella MA
Yoshizumi M
P304
P356
10.1161/01.RES.73.1.205
P577
1993-07-01T00:00:00Z